Agent for prophylaxis and treatment of diabetic complications
    1.
    发明申请
    Agent for prophylaxis and treatment of diabetic complications 审中-公开
    糖尿病并发症预防和治疗药物

    公开(公告)号:US20060148875A1

    公开(公告)日:2006-07-06

    申请号:US11363202

    申请日:2006-02-28

    IPC分类号: A61K31/4164

    摘要: The present invention relates to an agent for the prophylaxis and treatment of diabetic complications comprising, as an active ingredient, 4-[α-hydroxy-2-methyl-5-(1-imidazolyl)benzyl]-3,5-dimethylbenzoic acid, an optically active compound thereof or a pharmaceutically acceptable salt thereof. The present invention further relates to a method for the prophylaxis and treatment of diabetic complications comprising administering an effective amount of this compound. The medicament of the present invention is useful for the prophylaxis and treatment of diabetic complications, namely, diabetic neuropathy, nephropathy, ophthalmopathy, arteriosclerosis and the like. The action of the drug is long-lasting for very small doses and a single administration a day is sufficient.

    摘要翻译: 本发明涉及用于预防和治疗糖尿病并发症的药剂,其包含作为活性成分的4- [α-羟基-2-甲基-5-(1-咪唑基)苄基] -3,5-二甲基苯甲酸, 其光学活性化合物或其药学上可接受的盐。 本发明还涉及预防和治疗糖尿病并发症的方法,包括给予有效量的该化合物。 本发明的药物可用于预防和治疗糖尿病并发症,即糖尿病性神经病,肾病,眼病,动脉硬化等。 药物的作用对于非常小的剂量是持久的,每天一次给药是足够的。

    Prophylaxis and treatment of diabetic complications with
4-[.alpha.-hydroxy-2-methyl-5-(1-imidazolyl)
benzyl]-3,5-dimethylbenzoic acid
    2.
    发明授权
    Prophylaxis and treatment of diabetic complications with 4-[.alpha.-hydroxy-2-methyl-5-(1-imidazolyl) benzyl]-3,5-dimethylbenzoic acid 失效
    用4- [α-羟基-2-甲基-5-(1-咪唑基)苄基] -3,5-二甲基苯甲酸预防和治疗糖尿病并发症

    公开(公告)号:US6060496A

    公开(公告)日:2000-05-09

    申请号:US91993

    申请日:1998-06-26

    摘要: The present invention relates to an agent for the prophylaxis and treatment of diabetic complications comprising, as an active ingredient, 4-[.alpha.-hydroxy-2-methyl-5-(1-imidazolyl) benzyl]-3,5-dimethylbenzoic acid, an optically active compound thereof or a pharmaceutically acceptable salt thereof. The present invention further relates to a method for the prophylaxis and treatment of diabetic complications comprising administering an effective amount of this compound. The medicament of the present invention is useful for the prophylaxis and treatment of diabetic complications, namely, diabetic neuropathy, nephropathy, ophthalmopathy, arteriosclerosis and the like. The action of the drug is long-lasting for very small doses and a single administration a day is sufficient.

    摘要翻译: PCT No.PCT / JP96 / 03776 Sec。 371日期:1998年6月26日 102(e)日期1998年6月26日PCT 1996年12月24日PCT公布。 公开号WO97 / 24333 日期:1997年7月10日本发明涉及用于预防和治疗糖尿病并发症的药剂,其包含作为活性成分的4- [α-羟基-2-甲基-5-(1-咪唑基)苄基] -3, 5-二甲基苯甲酸,其光学活性化合物或其药学上可接受的盐。 本发明还涉及预防和治疗糖尿病并发症的方法,包括给予有效量的该化合物。 本发明的药物可用于预防和治疗糖尿病并发症,即糖尿病性神经病,肾病,眼病,动脉硬化等。 药物的作用对于非常小的剂量是持久的,每天一次给药是足够的。

    Method for prophylaxis and treatment of diabetic complications with 4{alpha-hydroxy-2-methyl-5-(1-imidazolyl)benzyl}-3,5-dimethylbenzoic acid and derivatives
    3.
    发明申请
    Method for prophylaxis and treatment of diabetic complications with 4{alpha-hydroxy-2-methyl-5-(1-imidazolyl)benzyl}-3,5-dimethylbenzoic acid and derivatives 审中-公开
    用4种{α-羟基-2-甲基-5-(1-咪唑基)苄基} -3,5-二甲基苯甲酸及其衍生物预防和治疗糖尿病并发症的方法

    公开(公告)号:US20050239856A1

    公开(公告)日:2005-10-27

    申请号:US11152376

    申请日:2005-06-15

    摘要: The present invention relates to an agent for the prophylaxis and treatment of diabetic complications comprising, as an active ingredient, 4-[α-hydroxy-2-methyl-5(1-imidazolyl)benzyl]-3,5-dimethylbenzoic acid, an optically active compound thereof or a pharmaceutically acceptable salt thereof. The present invention further relates to a method for the prophylaxis and treatment of diabetic complications comprising administering an effective amount of this compound. The medicament of the present invention is useful for the prophylaxis and treatment of diabetic complications, namely, diabetic neuropathy, nephropathy, ophthalmopathy, arteriosclerosis and the like. The action of the drug is long-lasting for very small doses and a single administration a day is sufficient.

    摘要翻译: 本发明涉及用于预防和治疗糖尿病并发症的药物,其包含作为活性成分的4- [α-羟基-2-甲基-5(1-咪唑基)苄基] -3,5-二甲基苯甲酸, 其光学活性化合物或其药学上可接受的盐。 本发明还涉及预防和治疗糖尿病并发症的方法,包括给予有效量的该化合物。 本发明的药物可用于预防和治疗糖尿病并发症,即糖尿病性神经病,肾病,眼病,动脉硬化等。 药物的作用对于非常小的剂量是持久的,每天一次给药是足够的。

    Method for prophylaxis and treatment of diabetic complications with 4[&agr;-hydroxy-2-methyl-5-(1-imidazolyl)benzyl]-3,5-dimethylbenzoic acid and derivatives
    4.
    发明授权
    Method for prophylaxis and treatment of diabetic complications with 4[&agr;-hydroxy-2-methyl-5-(1-imidazolyl)benzyl]-3,5-dimethylbenzoic acid and derivatives 有权
    用4α-羟基-2-甲基-5-(1-咪唑基)苄基] -3,5-二甲基苯甲酸及其衍生物预防和治疗糖尿病并发症的方法

    公开(公告)号:US06258834B1

    公开(公告)日:2001-07-10

    申请号:US09498481

    申请日:2000-02-04

    IPC分类号: A61K314164

    摘要: The present invention relates to an agent for the prophylaxis and treatment of diabetic complications comprising, as an active ingredient, 4-[&agr;-hydroxy-2-methyl-5-(1-imidazolyl)benzyl]-3,5-dimethylbenzoic acid, an optically active compound thereof or a pharmaceutically acceptable salt thereof. The present invention further relates to a method for the prophylaxis and treatment of diabetic complications comprising administering an effective amount of this compound. The medicament of the present invention is useful for the prophylaxis and treatment of diabetic complications, namely, diabetic neuropathy, nephropathy, ophthalmopathy, arteriosclerosis and the like. The action of the drug is long-lasting for very small doses and a single administration a day is sufficient.

    摘要翻译: 本发明涉及用于预防和治疗糖尿病并发症的药剂,其包含作为活性成分的4- [α-羟基-2-甲基-5-(1-咪唑基)苄基] -3,5-二甲基苯甲酸, 其光学活性化合物或其药学上可接受的盐。 本发明还涉及预防和治疗糖尿病并发症的方法,包括给予有效量的该化合物。 本发明的药物可用于预防和治疗糖尿病并发症,即糖尿病性神经病,肾病,眼病,动脉硬化等。 药物的作用对于非常小的剂量是持久的,每天一次给药是足够的。